Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business models in the financial capital. He has been recognised by heading Alzheimer’s disease drug trials for the UK market by venturing a new drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia and Yemen. Singh attained his education at The Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and Development.
Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning, auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management.
Executive Director – TAJ PHARMA GROUP
International Business Operations, Communication and International Conference, Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture handling.
Management Strategic Consulting including business plan & international sales strategy development.
Corporate Communication, Global Media and Press Releases, Spokesperson European Communication, Communication advisory team. Finance department Leadership and advisory committee. Annual Reports drafting team.
Subsidiary Planning and Implementations, Pharmaceuticals API and Chemicals Research and development.
Countries: EU – UK, Ireland, Poland, Germany, Austria, Romania, Luxomburg, France
Africa – Kenya, South Africa, Ghana, Ivory Coast, Senegal
Russia & CIS – Moscow, Turkmenistan
Specialties: Pharmaceuticals Distribution and Market Launches, Pharma Sales, financial consulting and corporate venture capital. International Corporate Communications and Mass media management. Finance and Accounting: Financial Management with broad experience in all aspects of accounting, tax planning and auditing.
Others: Experience in Product Marketing, Pharma Recruitment, Regulatory Submissions, Dossier Preparation, Qualifications and Validations, WHO/GMP Audits, Compliance and Risk Assessment and R&D Documentation.
Founder & CEO – TAJ INFOTECH INC.
Knowledge is Key to today’s Information Age, this is a New Type of I.T. Firm, provides a full range of innovative Web presence products & services to Web Hosts, Web Designers, Technology Consultants and I.T Resellers worldwide. Most innovative cloud technology by our global data centers based in Austin, UK, India and Hong Kong. more: http://shop.tajinfotech.com/
Creative Director – TAJ AGRO
Location: Mumbai Area, India
Introducing New Products, Business Re-modeling, Business Restructuring, Recovery and turnaround.
Director Sales – Taj API
Location: Mumbai Area, India
Taj Active Pharmaceutical Ingredients (or Taj API) is an international pharmaceutical api company based in India. Taj Api introduced Oseltamivir Phosphate ( INN) which is drug used for H5N1 avian influenza. The company was first to manufacture the raw martial for such a cause in India.
About Taj Pharma
Taj Pharmaceuticals is the global leader in generics and one of the India’s top ten pharmaceutical companies. Taj Pharma India play a leading role in therapeutic areas such as cancer, virology and transplantation. The combined strengths of Taj Pharma generics and pharmaceuticals businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients’ needs. Taj Pharmaceutical’s products and services address the entire healthcare spectrum, from screening for genetic risk factors, to preventing, diagnosing and treating disease, and monitoring the treatment response.
Taj Pharma India delivers a unique contribution to better healthcare. Taj Pharma India aim to reduce suffering and improve health and quality of life of people all around the world. At Taj Pharmaceuticals, Taj Pharma India have pursued this mission with patience, dedication, imagination and skill, for over a century. Taj Pharma vision is to develop targeted medicines and diagnostic tools that combine to offer patients, physicians and payers better, safer, more cost-effective healthcare.
Once again, welcome to Taj Pharmaceuticals, a great company that is translating a great vision into reality – We Innovate Healthcare.
Taj Pharmaceuticals Limited is committed to earning the trust of doctors, patients and customers every day. Taj Pharma colleagues worldwide believe that trust is not easily granted, and that is the reason Taj Pharma India focus each day on becoming a champion for Taj Pharma stakeholders.
During the past ten years, Taj Pharmaceuticals Group has been building a new kind of health care company. Throughout Taj Pharma Group (India), there’s a desire to build long-term relationships with Taj Pharma stakeholders based on mutual confidence. This is evident in many ways. Taj Pharma scientists are earning trust through the discovery and development of innovative, science-based medicines and services that improve the health and overall well-being of people around the world. Taj Pharma sales professionals, marketing teams, colleagues working at Taj Pharma plants and others throughout the organization at all levels of responsibility take each day as a fresh opportunity to earn trust.
All of this takes hard work, sharp execution, integrity and transparency on the part of Taj Pharmaceuticals Group colleagues. Taj Pharma global team is working to sustain and expand innovative new treatments. Taj Pharma India’re determined to do Taj Pharma part to increase access to better health care for all people. And, Taj Pharma India is focused on becoming the best in three key strategic areas: people, products and processes.
Taj Pharma India’re beginning to see the results of Taj Pharma efforts, but believe the best is yet to come. The test of being a true champion is to never give up and to passionately strive for even better outcomes. From Taj Pharma perspective as a health care company, that means helping people around the world live better and live longer.
Taj Pharma Group
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.
Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.
Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.
While individual Taj companies have differing geographical imperatives, the Taj Pharma Group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.
Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited, sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today.” We have already progressed on such efforts by our current presence in more than 40 countries.